Experimental Hematology & Oncology is calling for submissions to our Collection on 'Tumor Microenvironment, Metabolism and Immune Response.' This collection aims to bring together advanced researches that addresses the dynamic interaction between tumor cells and the surrounding stroma-immune cells, metabolism regulation and immune response in tumor microenvironment. For more information, visit the full Collection page.
Call for papers: Tumor Microenvironment, Metabolism and Immune Response
Call for papers: Oncobiome
The new cross journal collection 'Oncobiome' is now open for submissions. The oncobiome encompasses the diverse microbial communities residing in and on the human body, which influence cancer development, progression, and treatment responses. By examining these interactions, our aim is to unravel the complex mechanisms through which the microbiome impacts oncogenesis and therapeutic outcomes. For more information, visit the collection webpage.
Call for papers: Latest updates from major conferences
This Experimental Hematology & Oncology and Journal of Hematology & Oncology series intends to publish Correspondences with latest updates on novel agents and regimens from major conferences on blood and cancer disorders. Each Correspondence serves as a summary and analysis of 5 or more abstracts on a similar focus from a major international conference. Submissions can be made via the journal's submission system. For more information, visit the full collection page.
Articles
-
-
Unravelling neutropenic enterocolitis: insights from gut microbiota, and intestinal barrier analyses
-
Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study
-
Epstein-Barr virus infection following allogeneic hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
-
Superiority of targeted RNA sequencing for fusion detection and subtype diagnosis in Chinese sarcoma patients: a multicenter study
-
Breast cancer brain metastases: the last frontier
-
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy
-
COVID-19 vaccination associated severe immune thrombocytopenia
-
Leukemia incidence trends at the global, regional, and national level between 1990 and 2017
-
Complex roles of cAMP–PKA–CREB signaling in cancer
Breast Cancer Awareness Month 2024
October is breast cancer awareness month. We are standing together to raise awareness about breast cancer, a disease that affects millions of lives worldwide. Awareness and research are essential for early detection, better treatments, and ultimately saving lives. Take a look at these influential articles which aim to promote further research into breast cancer treatments and testing.
Aims and scope
Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.
Editors-in-Chief
Delong Liu, New York Medical College
Kongming Wu, Tongji Medical College
Editor's quote (Dr. Delong Liu)
"Like our companion journal, Journal of Hematology & Oncology, Experimental Hematology & Oncology publishes on all aspects of hematology and oncology, which are closely intertwined and rapidly evolving fields. It also emphasizes basic and translational research, as well as patient-oriented research and clinical trials with ‘negative’ or preliminary results. The journal is an international platform for sharing findings in these areas and adheres to fast turnaround times."
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 9.4
5-year Journal Impact Factor: 8.3
Source Normalized Impact per Paper (SNIP): 1.583
SCImago Journal Rank (SJR): 2.384Speed 2024
Submission to first editorial decision (median days): 2
Submission to acceptance (median days): 100Usage 2024
Downloads: 794,118
Altmetric mentions: 272